• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Biden-Harris administration using taxpayer money to mask Medicare premium hikes before election: critics

by August 14, 2024
written by August 14, 2024

In a move critics say is designed to shield the Biden-Harris administration from election fallout, the administration has leveraged taxpayer funds to mask upcoming increases in Medicare premiums.

Under the Inflation Reduction Act (IRA), which was intended to cap out-of-pocket drug costs for Medicare beneficiaries, insurers are poised to significantly hike monthly premiums, with average bids for Part D plans expected to triple by 2025.

In response to potential voter backlash, the Centers for Medicare and Medicaid Services (CMS) rolled out a three-year ‘demonstration project’ to subsidize these premiums, aiming to keep them artificially low. However, despite the appearance of relief, some critics are saying that taxpayers will fund a dramatic increase in subsidies — from $30 per recipient per month in 2024 to $142.70 in 2025 — raising concerns about the long-term impact on government spending and debt. 

Former President Trump advisor Joe Grogan has criticized the maneuver, arguing that it merely shifts costs rather than providing real relief.

‘They’ve destroyed part D premiums,’ Grogan told Fox News Digital in an interview. ‘I’m not sure it’ll survive legal scrutiny if someone were to sue. Objectively, it shouldn’t be done. It’s just interjecting $5-10 billion of taxpayer dollars, while the taxpayers are paying the price 85 days before an election. It’s sickening.’

‘This is only going to get worse in 2025, 2026,’ Grogan continued. ‘The program is in a death spiral. They announced a three-year demo. It’s already broken. The demo is going to fail. Premiums are still going to go up.’

Paragon Health Institute, a health care research group, called the CMS demo plan a ‘fake, costly demonstration,’ in a recent analysis. 

‘Fearing the premium increases that the IRA redesign will impose on Part D plans, CMS has now launched a new voluntary, nationwide demonstration program that is neither a demonstration nor voluntary. Unlike this massive subsidization scheme, demonstrations are supposed to be limited in nature and test alternative features of program design,’ the institute wrote. ‘As a result of the IRA changes, insurers that don’t participate are expected to either be uncompetitive from a price perspective or face significant losses – hardly a choice for insurers.’

Research published by Fidelity, an investment research group, shows that a 65-year-old retiring today can expect to spend $165,000 on health care in retirement, a 5% increase from last year and more than double the estimate from 2002.

Yet, there appears to be a disconnect for many Americans between the actual projected cost of health care in retirement and how much they expect to spend on those expenses. The average American thinks they will spend about $75,000 on health care and other medical expenses, less than half of Fidelity’s calculation, according to the research.

The estimate assumes that an individual is enrolled in Medicare – including Part A and Part B, which cover most hospital care and doctor’s visits – and Part D, which covers prescription drugs. Other expenses such as Medicare premiums, over-the-counter medications, dental and vision care and other costs typically not covered by Medicare are ‘left to retirees to manage on their own,’ the report said.

As of April 2024, about 67.3 million Americans were enrolled in Medicare, according to the Centers for Medicare and Medicaid Services. Of those, about half were enrolled in a Medicare Advantage plan, while about 80% were covered by Medicare Part D.

‘They just want to get through the election,’ Grogan said. ‘They’re hoping after the election they can face it, but its gonna need to be dealt with in the next 12–18 months. They did not believe it would be this bad and its only gonna get worse.’ 

Americans are also dealing with a spike in the cost of prescription drugs, which has surged nearly 40% over the past decade, easily outstripping the pace of inflation. 

Fox News Digital has reached out to CMS for comment. 

Fox Business’ Megan Henney contributed to this report. 

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Oil and natural gas: oil price in retreat since Tuesday
next post
The dollar index under strong bearish pressure this week

related articles

Trump doubles down on voiding Biden autopen actions,...

December 3, 2025

Hegseth erupts over WaPo ‘fake stories’, vows to...

December 3, 2025

GOP fractures over Hegseth’s ‘double-tap’ Caribbean strike as...

December 2, 2025

Trump lays out where he stands with Elon...

December 2, 2025

Hegseth erupts over WaPo ‘fake stories’ smear, vows...

December 2, 2025

Taxpayers on the hook for lawn care, fixing...

December 2, 2025

Experts dispute Nigerian government’s claims amid congressional probe...

December 2, 2025

Putin warns Russia ‘ready’ if Europe ‘suddenly wants...

December 2, 2025

Rosie O’Donnell says daughter blames Trump for forcing...

December 2, 2025

Johnson points to Obama-era drone precedent as Congress...

December 2, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Balance of power: Jockeying begins for House Freedom Caucus top spot after leader’s unprecedented primary loss

    August 4, 2024
  • What’s next in the Russia, Ukraine ceasefire talks?

    March 19, 2025
  • At least 26 American hostages released since Trump took office

    April 12, 2025
  • Trump says he had ‘productive’ call with Turkey’s Erdogan about Russia-Ukraine war, Gaza

    May 5, 2025
  • Modern Trade vs General Trade Management

    August 19, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (6,937)
  • Investing (634)
  • Stock (958)

Latest Posts

  • Melania Trump’s pro-choice stand isn’t that different from other Republican first ladies

    October 4, 2024
  • Harris dodging flip-flop attacks as faceless surrogates flip key positions: ‘Playing politics’

    August 15, 2024
  • Trump set to meet with world leaders in DC during busy week as Russia-Ukraine peace talks continue

    February 23, 2025

Recent Posts

  • Republicans struggle with Trump’s mixed signals on ‘big, beautiful bill’

    May 15, 2025
  • Can Trump force Hamas to free the hostages they’re holding?

    December 18, 2024
  • USAID’s green energy programs have maximized harm to the developing world, according to former official

    February 13, 2025

Editor’s Pick

  • Bronfman’s Paramount bid could keep Shari Redstone involved at the company

    August 26, 2024
  • Kirby slams Hamas chief Sinwar as ‘the major obstacle’ to cease-fire, hostage release deal with Israel

    September 22, 2024
  • Harris campaign abandons Biden in final weeks before Election Day: report

    October 20, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock